ReNAgade Therapeutics Launches with over $300 Million in Series A Financing To Unlock the Limitless Potential of RNA Medicine
Company built on foundation of novel, proprietary delivery technologies and an integrated, multimodal, all-RNA platform to deliver, code, edit, and insert genetic information to correct...